US EditionPublished • loading... • Updated
Researchers identify key factor to help improve treatment for glioblastoma
Administering miR-181d reduces variability in MGMT protein levels within glioblastoma tumors, enhancing chemotherapy effectiveness according to Brown University researchers.
Summary by News Medical
2 Articles
2 Articles
Researchers identify key factor to help improve treatment for glioblastoma
A groundbreaking study from Brown University Health researchers has identified a crucial factor that may help improve treatment for glioblastoma, one of the most aggressive and common forms of adult brain cancer.
·United States
Read Full Article
Taming Tumor Chaos: Researchers Uncover Key to Improving Glioblastoma Treatment
A groundbreaking study identifies a "master switch" molecule, miR-181d, that controls the chaotic behavior of glioblastoma cells. By stabilizing this molecule, researchers can force tumor cells into a more uniform state, significantly increasing their vulnerability to chemotherapy.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
